Education
About Us
Working with TipRanks
Follow Us
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
Earnings Data
Report Date
Mar 04, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.32Last Year’s EPS
-0.53Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a positive outlook with strong leadership transitions, a robust financial position, and significant achievements in partnerships and platform development. However, there are challenges related to drug safety and clinical uncertainty that require careful management.Company Guidance
New Leadership Announcement
Najat Khan will become the new CEO, President, and Director of Recursion from January 1, 2026. Chris Gibson will continue as the Chairman of the Board and Executive Adviser.
Strong Financial Position
Recursion holds a pro forma cash balance of $785 million, providing runway through the end of 2027 without additional financing.
Significant Partnership Milestone
Recursion earned a $30 million milestone payment from Roche and Genentech for the delivery of a whole genome neuro map, contributing to over $500 million in total partnership inflows.
Advanced Drug Discovery Platform
Recursion has developed an automated ADMET platform for drug-like molecule design and has delivered the world's largest iPSC-derived neuronal and microglial cell maps.
RXRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RXRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $5.00 | $4.96 | -0.80% |
Aug 05, 2025 | $5.80 | $5.53 | -4.66% |
May 05, 2025 | $5.70 | $4.76 | -16.49% |
Feb 28, 2025 | $7.67 | $7.51 | -2.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Recursion Pharmaceuticals (RXRX) report earnings?
Recursion Pharmaceuticals (RXRX) is schdueled to report earning on Mar 04, 2026, Before Open (Confirmed).
What is Recursion Pharmaceuticals (RXRX) earnings time?
Recursion Pharmaceuticals (RXRX) earnings time is at Mar 04, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RXRX EPS forecast?
RXRX EPS forecast for the fiscal quarter 2025 (Q4) is -0.32.